Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
Price to Cash Earnings (PCE)

    Back to All Ratios
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   PCE(x) 35.8432.7622.4916.66-

What is the latest Price to Cash Earnings (PCE) ratio of PIRAMAL PHARMA ?

The latest Price to Cash Earnings (PCE) ratio of PIRAMAL PHARMA is 35.84 based on Mar2026 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202635.84
Mar202532.76
Mar202422.49
Mar202316.66
Mar2022-

How is Price to Cash Earnings (PCE) of PIRAMAL PHARMA Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2026 35.84
9.40
Mar2025 32.76
45.66
Mar2024 22.49
34.99
Mar2023 16.66
0
Mar2022 0 -

Other Financial Ratios of PIRAMAL PHARMA


Compare Price to Cash Earnings (PCE) ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹23,311.1 Cr 3.9% 5% -12.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,593.0 Cr 2% 6.7% 14.1% Stock Analytics
DIVIS LABORATORIES ₹179,737.0 Cr 3.5% 2.2% 0.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹164,290.0 Cr 4.6% 9.9% 41.5% Stock Analytics
CIPLA ₹117,327.0 Cr -0.3% 3.7% -2.3% Stock Analytics
DR REDDYS LABORATORIES ₹112,994.0 Cr 1.1% 5.9% 6.6% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

3.9%

5%

-12.5%

SENSEX

2.2%

5.1%

-7%


You may also like the below Video Courses